How Selegiline ((-)-Deprenyl) Slows Brain Aging

作者: Joseph Knoll

DOI:

关键词:

摘要:

参考文章(133)
M. Ebadi, S. Sharma, S. Shavali, H. El Refaey, Neuroprotective actions of selegiline. Journal of Neuroscience Research. ,vol. 67, pp. 285- 289 ,(2002) , 10.1002/JNR.10148
Gian Luigi Piccinin, Giancarlo Finali, Massimo Piccirilli, Neuropsychological Effects of L-Deprenyl in Alzheimer's Type Dementia Clinical Neuropharmacology. ,vol. 13, pp. 147- 163 ,(1990) , 10.1097/00002826-199004000-00004
Wilson M. Compton, Kevin P. Conway, Frederick S. Stinson, Bridget F. Grant, Changes in the Prevalence of Major Depression and Comorbid Substance Use Disorders in the United States Between 1991-1992 and 2001-2002 American Journal of Psychiatry. ,vol. 163, pp. 2141- 2147 ,(2006) , 10.1176/AJP.2006.163.12.2141
Mounira Banasr, Ronald S. Duman, Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors Biological Psychiatry. ,vol. 64, pp. 863- 870 ,(2008) , 10.1016/J.BIOPSYCH.2008.06.008
E. Fischer, H. Spatz, B. Heller, H. Reggiani, Phenethylamine content of human urine and rat brain, its alterations in pathological conditions and after drug administration. Cellular and Molecular Life Sciences. ,vol. 28, pp. 307- 308 ,(1972) , 10.1007/BF01928707
H. Blaschko, D. Richter, H. Schlossmann, The inactivation of adrenaline The Journal of Physiology. ,vol. 90, pp. 1- 17 ,(1937) , 10.1113/JPHYSIOL.1937.SP003497
Shyamal H. Mehta, John C. Morgan, Kapil D. Sethi, Does Rasagiline Have a Disease-Modifying Effect on Parkinson’s Disease? Current Neurology and Neuroscience Reports. ,vol. 10, pp. 413- 416 ,(2010) , 10.1007/S11910-010-0133-3
A. J. Lees, Selegiline hydrochloride and cognition. Acta Neurologica Scandinavica. ,vol. 84, pp. 91- 94 ,(1991) , 10.1111/J.1600-0404.1991.TB05027.X